Population of Interest
- Patients resuscitated with blood products in deployed Role 3 Military Treatment Facilities.
Intent
- TSWB is only used when the recipient’s blood type is confirmed and identical TSWB is available
- LTOWB or appropriate component therapy featuring universal donor products is used when TSWB is not appropriate
- WBB is activated when indicated by senior surgeon
- Proper documentation is completed for each unit transfused.
- Any transfusion reaction is appropriately documented.
Performance/Adherence Metrics
- TSWB is used when blood type of the recipient has been confirmed by a laboratory
- LTOWB is used when the recipient’s blood type is unknown or not confirmed by a laboratory.
- Type A whole blood is used at the Role 3 MTF for Type A recipients when appropriate pretransfusion testing has been completed.
- Frequency of hemolytic transfusion reactions due to blood typing error or clerical error is documented and reported as a CCIR.
- Documentation of all blood products transfused to include time of transfusion.
Data Source
- Blood transfusion databases
- DoD Trauma Registry
- Patient Record